Immune mediated and inherited defences against flaviviruses

Clinical and Diagnostic Virology

Volumn 10, Issue 2-3, 1998, Pages 129-139

  Brinton, Margo A ^a   Kurane, Ichiro ^b   Mathew, Anuja ^b   Zeng, Lingling ^a   Yong Shi, Pei ^a   Rothman, Alan ^b   Ennis, Francis A ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b Dept Med Univ Massachusetts M ^*  (United States)

Author keywords

Flaviviral B cell epitope; Flaviviral T cell epitope; Flavivirus; Genetic resistance; Immune response; Non structural viral protein; Structural viral protein

Indexed keywords

VIRUS PROTEIN;

CELL CULTURE; CONFERENCE PAPER; EPITOPE MAPPING; FLAVIVIRUS; GENETIC RESISTANCE; HEMORRHAGIC FEVER; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE; NONHUMAN; PRIORITY JOURNAL; SHOCK; VIRUS INFECTION; VIRUS RESISTANCE;

ANIMALS; EPITOPE MAPPING; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FLAVIVIRUS; FLAVIVIRUS INFECTIONS; HUMANS; IMMUNITY, NATURAL; MICE; VIRAL PROTEINS;

ANIMALIA; FLAVIVIRUS; MURINAE; RNA VIRUSES; VACCINIA;

EID: 0032527485     PISSN: 09280197     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-0197(98)00039-7     Document Type: Conference Paper

References (56)

1. Brandriss M.W., Schlesinger J.J., Walsh E.E. Immunogenicity of a purified fragment of 17D yellow fever envelope protein. J Infect Dis. 161:1990;1134-1139.
2. Brinton M.A. Isolation of a replication-efficient mutant of West Nile virus from a persistently infected genetically resistant mouse cell culture. J Virol. 39:1981;413-421.
3. Brinton M.A. Analysis of extracellular West Nile virus particles produced by cell cultures from genetically resistant and susceptible mice indicates enhanced amplification of defective inferring particles by resistant cultures. J Virol. 96:1983;860-870.
4. Brinton MA. Host susceptibility to viral disease. In: Nathanson N, Ahmed R, Gonzalez-Scerano F, Griffin DE, Holmes, KV. Murphy FA, Robinson HL, editors. Viral Pathogenesis. Philadelphia: Lippincott-Raven, 1996: 303-328.
5. + human cytotoxic T lymphocytes. J Virol. 63:1989;5086-5091.
6. Darnell M.B., Koprowski H., Lagerspetz K. Genetically determined resistance to infection with group B arboviruses. I. Distribution of the resistance gene among various mouse populations and characteristics of gene expression in vivo. J Infect Dis. 129:1974;240-247.
7. Delenda C., Staropoli I., Frenkiel M.P., Cabanie L., Deubel V. Analysis of c-terminally truncated dengue 2 and dengue 3 viral envelope glycoproteins: processing in insect cells and immunogenic properties in mice. J Gen Virol. 75:1994;1569-1578.
8. Falconar A.K. The dengue virus nonstructural-1 protein (NS1) generates antibodies to common epitopes on human blood clotting, integrin/adhesion proteins and binds to human endothelial cells: potential implications in haemorrhagic fever pathogenesis. Arch Virol. 142:1997;897-916.
9. Falgout B., Bray M., Schlesinger J.J., Lai C.J. Immunization of mice with recombinant vaccinia virus expressing authentic dengue virus nonstructural protein NSI protects against lethal dengue virus encephalitis. J Virol. 64:1990;4356-4363.
10. +cytotoxic T-lymphocyte clones. J Virol. 70:1996;141-147.
11. Garcia G., Vaughn D.W., Del Angel R.M. Recognition of synthetic oligopeptides from nonstructural proteins NS1 and NS3 of dengue-4 virus by sera from dengue virus-infected children. Am J Trop Med Hyg. 56:1997;466-470.
12. Goodman G.T., Koprowski H. Study of the mechanism of innate resistance to virus infection. J Cell Comp Physiol. 59:1962;333-342.
13. Halstead S.B. Antibody, macrophages, dengue virus infection, shock, and hemorrhage, a pathogenic cascade. Rev Infect Dis. 11:1989;S830-S839.
14. Hill A.B., Müllbacher A., Parrish C., Coia G., Westaway E.G., Blanden R.V. Broad cross-reactivity with marked fine specificity in the cytotoxic T-cell response to flaviviruses. J Gen Virol. 73:1992;1115-1123.
15. Huang J.H., Wey J.J., Lee H.F., Tsou T.L., Wu C.S., Wu J.R., Chen H.M., Chin C., Chien L.J., Chen L.K., Wu Y.C., Pan M.J., Wang T.M. Identification of immunodominant, group-specific and subcomplex-specific continuous epitopes in the core regions of Japanese encephalitis virus using synthetic peptides. Virus Res. 41:1996;43-53.
16. Iacono-Connors L.C., Smith J.F., Ksiazek T.G., Kelley C.L., Schmaljohn C.S. Characterization of Langat virus antigenic determinants defined by monoclonal antibodies to E, NS1 and pre M and identification of a protective, non-neutralizing preM-specific monoclonal antibody. Virus Res. 43:1996;125-136.
17. Kochel T., Wu S.J., Raviprakash K., Hobart P., Hoffman S., Porter K., Hayes C. Inoculation of plasmids expressing the dengue-2 envelope gene elicit neutralizing antibodies in mice. Vaccine. 15:1997;547-552.
18. +cytotoxic T lymphocytes in mice. Virology. 227:1997;353-360.
19. - cytotoxic T-cell clones: multiple patterns of virus cross-reactivity recognized by NS3-specific T-cell clones. J Virol. 65:1991;1823-1828.
20. +, and interferon-γ in sera of children with dengue. J Clin Invest. 88:1991;1473-1480.
21. - cytotoxic T-cell clone. J Virol. 67:1993;6285-6288.
22. Kurane I., Ennis F.A. Immunity and immunopathology in dengue virus infections. Semin Immunol. 4:1992;121-127.
23. - cytotoxic T lymphocyte clones. J Gen Virol. 76:1995;2243-2249.
24. + cytotoxic T lymphocyte clones cross-reactive for dengue virus types 2, 3 and 4. Virology. 240:1998;169-174.
25. +cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities. J Immunol. 154:1995;1287-1295.
26. Lobigs M., Arthur C.E., Müllbacher A., Blanden R.V. The flavivirus nonstructural protein NS3 is a dominant source of cytotoxic T-cell peptide determinants. Virology. 202:1994;195-201.
27. Lobigs M., Dalgarno L., Schlesinger J.J., Weir R.C. Location of a neutralization determinant in the E protein of yellow fever virus (17D vaccine strain). Virology. 161:1997;474-478.
28. +cytotoxic T lymphocytes of dengue virus nonstructural proteins NS3 and NS12a. J Clin Invest. 98:1996;1684-1691.
29. Mathew A, Kurane I, Green S, Stephens HAF, Vaughn DW, Kalayanaroof S, Suntayakorn S, Ennis FA, Rothman AL. Predominance of HLA-restricted CTL responses to serotype crossreactive epitopes on nonstructural proteins after natural dengue virus infections. J Virol. 72:1998;3999-4004.
30. Mathews J.H., Allan J.E., Roehrig J.T., Brubaker J.R., Uren M.F., Hunt A.R. T-helper cell and associated antibody response to synthetic peptides of the E glycoprotein of Murray Valley encephalitis virus. J Virol. 65:1991;5141-5148.
31. Mathews J.H., Roehrig J.T., Brubaker J.R., Hunt A.R., Allan J.E. A synthetic peptide to the E glycoprotein of Murray Valley encephalitis virus defines multiple virus-reactive T-and B-cell epitopes. J Virol. 66:1992;6555-6562.
32. Matveeva V.A., Popova R.V., Kvetkova E.A., Chernicina L.O., Zlobin V.I., Puchovskaya N.M., Morozova O.V. Antibodies against tick-borne encephalitis virus (TBEV) non-structural and structural proteins in human sera and spinal fluid. Immunol Lett. 46:1995;1-4.
33. Megret F., Hugnot J.P., Falconar A., Gentry M.K., Morens D.M., Murray J.M., Schlesinger J.J., Wright P.J., Young P., Van Rengenmortel M.H.V., Deubel V. Use of recombinant fusion proteins and monoclonal antibodies to define linear and discontinuous antigenic sites on the dengue virus envelope glycoprotein. Virology. 187:1992;480-491.
34. Murali-Krishna K., Ramireddy B., Rave V., Manjunath R. Recognition of nonstructural protein peptides by cytotoxic T lymphocytes raised against Japanese encephalitis virus. Microbiol Immunol. 39:1995;1021-1024.
35. Putnak J.R., Schlesinger J.J. Protection of mice against yellow fever virus encephalitis by immunization with a vaccinia virus recombinant encoding the yellow fever virus non-structural proteins, NS1, NS2a and NS2b. J Gen Virol. 71:1990;1697-1702.
36. Roehrig J.T., Hunt A.R., Johnson A.J., Hawkes R.A. Synthetic peptides derived from the deduced amino acid sequence of the E-glycoprotein of Murray Valley encephalitis virus elicit antiviral antibody. Virology. 171:1989;49-60.
37. Roehrig J.T., Johnson A.J., Hunt A.R., Bolin R.A., Chu M.C. Antibodies to dengue 2 virus E-glycoprotein synthetic peptides identify antigenic conformation. Virology. 66:1990;668-675.
38. Roehrig J.T., Johnson A.J., Hunt A.R., Beaty B.J., Mathews J.H. Enhancement of the antibody response to flavivirus B-cell epitopes by using homologous or heterologous T-cell epitopes. J Virol. 66:1992;3385-3390.
39. Roehrig J.T., Risi P.A., Brubaker J.R., Hunt A.R., Beaty B.J., Trent D.W., Mathews J.H. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology. 198:1994;31-38.
40. Roehrig J.T., Risi P.A., Brubaker J.R., Hunt A.R., Beaty B.J., Trent D.W., Mathews J.H. T-helper cell epitopes on the E-glycoprotein of dengue 2 Jamaica virus. Virology. 198:1994;31-38.
41. +T-cell response to dengue virus. J Virol. 70:1996;6540-6546.
42. Ryman K.D., Ledger T.N., Weir R.C., Schlesinger J.J., Barrett A.D. Yellow fever virus envelope protein has two discrete type-specific neutralizing epitopes. J Gen Virol. 78:1997;1353-1356.
43. Schlesinger J.J., Foltzer M., Chapman S. The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology. 192:1993;132-141.
44. Schlesinger J.J., Chapman S. Neutralizing F(ab')2 fragments of protective monoclonal antibodies to yellow fever virus (YF) envelope protein fail to protect mice against lethal YF encephalitis. J Gen Virol. 76:1995;217-220.
45. Seif S.A., Morita K., Matsuo S., Hasebe F., Igarashi A. Finer mapping of neutralizing epitope(s) on the C-terminal of Japanese encephalitis virus E-protein expressed in recombinant Escherichia coli system. Vaccine. 13:1995;1515-1521.
46. Shallem G.R., Urosevic N., Sangster M.Y., Mansfield J.P., Mackenzie J.S. Characterization of allelic forms at the retinal degeneration (rd) and b-glucuronidase (Gus) loci for the mapping of the flavivirus resistance (Flv) gene on the mouse chromosome 5. Mouse Genome. 91:1993;572-574.
47. Shi P.-Y., Li W., Brinton M.A. Cell proteins bind specifically to the 3' stem-loop structure of West Nile virus minus-strand RNA. J Virol. 70:1996;6278-6287.
48. Smucny J.J., Kelly E.P., Macarthy P.O., King A.D. Murine immunoglobin G subclass responses following immunization with live dengue virus or a recombinant dengue envelope protein. Am J Trop Med Hyg. 53:1995;432-437.
49. Staropoli I., Frenkiel M.-P., Mégret F., Deubel V. Affinity-purified dengue-2 virus envelope glycoprotein induces neutralizing antibodies and protective immunity in mice. Vaccine. 15:1997;1946-1954.
50. Vainio T. Virus and hereditary resistance in vitro. I. Behavior of West Nile (E-101) virus in the cultures prepared from genetically resistant and susceptible strains of mice. Ann Med Exp Biol Fenn. 41:1963;1-24.
51. Venugopal K., Shiu S.Y., Gould E.A. Recombinant vaccinia virus expressing PrM and E glycoproteins of louping ill virus: induction of partial homologous and heterologous protection in mice. Res Vet Sci. 57:1994;188-193.
52. Whittle B.L., Lee E., Weir R.C., Verma N.K. Immune response to a Murray Valley encephalitis virus epitope expressed in the flagellin of an attenuated strain of Salmonella. J Med Microbiol. 46:1997;129-138.
53. Winkler G., Maxwell S.E., Ruemmler C., Stollar V. Newly synthesized dengue-2 virus nonstructural protein NS1 is a soluble protein but becomes partially hydrophobic and membrane-associated after dimerization. Virology. 171:1989;302-305.
54. Yao Z.J., Kao M.C., Loh K.C., Chung N.C. A serotype-specific epitope of dengue virus 1 identified by phage displayed random peptide library. FEMS Microbiol Lett. 127:1995;93-98.
55. +T-cell clones. J Virol. 70:1996;3108-3117.
56. + human cytotoxic T lymphocyte clones of heterogeneous serotype specificities. J Exp Med. 182:1995;853-863.